These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30383714)

  • 1. MANAGEMENT OF NEOVASCULAR OCULAR HISTOPLASMOSIS: Past and Present.
    Blinder KJ
    Retina; 2019 Feb; 39(2):226-234. PubMed ID: 30383714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presumed ocular histoplasmosis.
    Thuruthumaly C; Yee DC; Rao PK
    Curr Opin Ophthalmol; 2014 Nov; 25(6):508-12. PubMed ID: 25237930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal bevacizumab for choroidal neovascularization secondary to presumed ocular histoplasmosis syndrome.
    Ehrlich R; Ciulla TA; Maturi R; Kheradiya NS; Hrisomalos N; Shulman S; Guess MG; Coyle E; Harris A
    Retina; 2009; 29(10):1418-23. PubMed ID: 19898179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New and classic insights into presumed ocular histoplasmosis syndrome and its treatment.
    Oliver A; Ciulla TA; Comer GM
    Curr Opin Ophthalmol; 2005 Jun; 16(3):160-5. PubMed ID: 15870572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical management of choroidal neovascular membranes.
    Hochman MA; Weiter JJ; Fleckner MR; Buzney SM; Tolentino FI
    Int Ophthalmol Clin; 1999; 39(1):303-15. PubMed ID: 10083925
    [No Abstract]   [Full Text] [Related]  

  • 6. PRN Ranibizumab in the Treatment of Choroidal Neovascularization Secondary to Ocular Histoplasmosis.
    Wood EH; Whitted RJ; Stone TW; Isernhagen RD; Wood WJ; Holcomb DM; Kitchens JW
    Ophthalmic Surg Lasers Imaging Retina; 2018 Jan; 49(1):20-26. PubMed ID: 29304262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five-year follow-up of fellow eyes of individuals with ocular histoplasmosis and unilateral extrafoveal or juxtafoveal choroidal neovascularization. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1996 Jun; 114(6):677-88. PubMed ID: 8639078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Submacular surgery for subfoveal choroidal neovascular membranes in patients with presumed ocular histoplasmosis.
    Berger AS; Conway M; Del Priore LV; Walker RS; Pollack JS; Kaplan HJ
    Arch Ophthalmol; 1997 Aug; 115(8):991-6. PubMed ID: 9258220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presumed ocular histoplasmosis syndrome: update on epidemiology, pathogenesis, and photodynamic, antiangiogenic, and surgical therapies.
    Ciulla TA; Piper HC; Xiao M; Wheat LJ
    Curr Opin Ophthalmol; 2001 Dec; 12(6):442-9. PubMed ID: 11734684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal bevacizumab as initial treatment for choroidal neovascularization associated with presumed ocular histoplasmosis syndrome.
    Adán A; Navarro M; Casaroli-Marano RP; Ortiz S; Molina JJ
    Graefes Arch Clin Exp Ophthalmol; 2007 Dec; 245(12):1873-5. PubMed ID: 17786466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Presumed ocular histoplasmosis syndrome (POHS)].
    Laghmari M; Lezrek O
    Pan Afr Med J; 2014; 18():268. PubMed ID: 25426215
    [No Abstract]   [Full Text] [Related]  

  • 12. Presumed ocular histoplasmosis syndrome.
    Prasad AG; Van Gelder RN
    Curr Opin Ophthalmol; 2005 Dec; 16(6):364-8. PubMed ID: 16264347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential Chorioretinal Changes in Presumed Ocular Histoplasmosis Syndrome Analyzed Using Spectral Domain Optical Coherence Tomography.
    Adhi M; Jusufbegovic D; Schaal S
    Ocul Immunol Inflamm; 2017 Aug; 25(4):545-553. PubMed ID: 27082105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development of choroidal neovascularization in pregnancy.
    Rhee P; Dev S; Mieler WF
    Retina; 1999; 19(6):520-4. PubMed ID: 10606452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal anti-vascular endothelial growth factor for choroidal neovascularization in ocular histoplasmosis.
    Hu J; Hoang QV; Chau FY; Blair MP; Lim JI
    Retin Cases Brief Rep; 2014; 8(1):24-9. PubMed ID: 25372202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Choroidal neovascularization after laser in situ keratomileusis in a patient with presumed ocular histoplasmosis syndrome.
    Fedorovich I; Mehr DS; Oz O; Akduman L
    Eur J Ophthalmol; 2004; 14(3):261-3. PubMed ID: 15206653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Argon green vs krypton red laser photocoagulation for extrafoveal choroidal neovascularization. One-year results in ocular histoplasmosis. The Canadian Ophthalmology Study Group.
    Arch Ophthalmol; 1994 Sep; 112(9):1166-73. PubMed ID: 7522003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Presumed ocular histoplasmosis syndrome].
    Seceleanu A; Călugăru M; Kaucsar E; Călugăru D
    Oftalmologia; 2004; 48(2):92-7. PubMed ID: 15341107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ranibizumab versus photodynamic therapy for presumed ocular histoplasmosis syndrome.
    Ramaiya KJ; Blinder KJ; Ciulla T; Cooper B; Shah GK
    Ophthalmic Surg Lasers Imaging Retina; 2013; 44(1):17-21. PubMed ID: 23410808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up of surgical removal of extensive peripapillary choroidal neovascularization in presumed ocular histoplasmosis syndrome.
    Almony A; Thomas MA; Atebara NH; Holekamp NM; Del Priore LV
    Ophthalmology; 2008 Mar; 115(3):540-545.e5. PubMed ID: 17988741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.